Your browser doesn't support javascript.
loading
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey.
Allen, Sophie; Loong, Lucy; Garrett, Alice; Torr, Bethany; Durkie, Miranda; Drummond, James; Callaway, Alison; Robinson, Rachel; Burghel, George J; Hanson, Helen; Field, Joanne; McDevitt, Trudi; McVeigh, Terri P; Bedenham, Tina; Bowles, Christopher; Bradshaw, Kirsty; Brooks, Claire; Butler, Samantha; Del Rey Jimenez, Juan Carlos; Hawkes, Lorraine; Stinton, Victoria; MacMahon, Suzanne; Owens, Martina; Palmer-Smith, Sheila; Smith, Kenneth; Tellez, James; Valganon-Petrizan, Mikel; Waskiewicz, Erik; Yau, Michael; Eccles, Diana M; Tischkowitz, Marc; Goel, Shilpi; McRonald, Fiona; Antoniou, Antonis C; Morris, Eva; Hardy, Steven; Turnbull, Clare.
Afiliación
  • Allen S; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK.
  • Loong L; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK.
  • Garrett A; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK.
  • Torr B; Department of Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Durkie M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK.
  • Drummond J; Sheffield Diagnostic Genetics Service, NEY Genomic Laboratory Hub, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Callaway A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Robinson R; Wessex Regional Genetics Laboratory, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Burghel GJ; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Hanson H; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Field J; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK.
  • McDevitt T; Department of Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London, UK.
  • McVeigh TP; Genomics and Molecular Medicine Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Bedenham T; Department of Clinical Genetics, CHI at Crumlin, Dublin, Ireland.
  • Bowles C; Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Bradshaw K; West Midlands, Oxford and Wessex Genomic Laboratory Hub, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Brooks C; Department of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Butler S; East Midlands and East of England Genomics Laboratory, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Del Rey Jimenez JC; North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Hawkes L; Central and South Genomic Laboratory Hub, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Stinton V; Department of Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London, UK.
  • MacMahon S; South East Genomics Laboratory Hub, Guy's Hospital, London, UK.
  • Owens M; North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, UK.
  • Palmer-Smith S; Centre for Molecular Pathology, Institute of Cancer Research Sutton, Sutton, UK.
  • Smith K; Department of Molecular Diagnostics, The Royal Marsden NHS Foundation Trust, London, UK.
  • Tellez J; Department of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Valganon-Petrizan M; Institute of Medical Genetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK.
  • Waskiewicz E; South West Genomic Laboratory Hub, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Yau M; North East and Yorkshire Genomic Laboratory Hub, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Eccles DM; Centre for Molecular Pathology, Institute of Cancer Research Sutton, Sutton, UK.
  • Tischkowitz M; Department of Molecular Diagnostics, The Royal Marsden NHS Foundation Trust, London, UK.
  • Goel S; Institute of Medical Genetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK.
  • McRonald F; South East Genomics Laboratory Hub, Guy's Hospital, London, UK.
  • Antoniou AC; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Morris E; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Hardy S; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Turnbull C; NHS England, National Disease Registration Service, London, UK.
J Med Genet ; 61(4): 305-312, 2024 Mar 21.
Article en En | MEDLINE | ID: mdl-38154813
ABSTRACT

BACKGROUND:

National and international amalgamation of genomic data offers opportunity for research and audit, including analyses enabling improved classification of variants of uncertain significance. Review of individual-level data from National Health Service (NHS) testing of cancer susceptibility genes (2002-2023) submitted to the National Disease Registration Service revealed heterogeneity across participating laboratories regarding (1) the structure, quality and completeness of submitted data, and (2) the ease with which that data could be assembled locally for submission.

METHODS:

In May 2023, we undertook a closed online survey of 51 clinical scientists who provided consensus responses representing all 17 of 17 NHS molecular genetic laboratories in England and Wales which undertake NHS diagnostic analyses of cancer susceptibility genes. The survey included 18 questions relating to 'next-generation sequencing workflow' (11), 'variant classification' (3) and 'phenotypical context' (4).

RESULTS:

Widely differing processes were reported for transfer of variant data into their local LIMS (Laboratory Information Management System), for the formatting in which the variants are stored in the LIMS and which classes of variants are retained in the local LIMS. Differing local provisions and workflow for variant classifications were also reported, including the resources provided and the mechanisms by which classifications are stored.

CONCLUSION:

The survey responses illustrate heterogeneous laboratory workflow for preparation of genomic variant data from local LIMS for centralised submission. Workflow is often labour-intensive and inefficient, involving multiple manual steps which introduce opportunities for error. These survey findings and adoption of the concomitant recommendations may support improvement in laboratory dataflows, better facilitating submission of data for central amalgamation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Laboratorios / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Med Genet Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Laboratorios / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Med Genet Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido